Genetic Testing Flashcards
1. Scope: 2. Techniques: 3. Risks and Benefits (see lecture notes)
Diagnostic Testing
confirmatory test or differential diagnosis testing for symptomatic individuals
heterozyote screening
within an at-risk family for a disease such as cystic fibrosis
- founder effect
- heterozygote advantage
pre-symptomatic testing
tests for variants causing or associated with disorders known to be inherited in the family often with *adult-onsetsymptoms”
pharmacogenetic testing
Purpose: drug dosing/ adverse reactions
Method: targeted testing
predictive testing
purpose: identification of variants causing or associated with adult on-set symptoms
prenatal diagnosis (4)
a. amniocentesis
b. chorionic villus sampling
c. percutaneous umbilical blood samplings
d. preimplantation genetic diagnosis
Technique: Biochemical Testing
genetic diseases with known biochemical defects (such as inborn errors of metabolism) were diagnosed by enzyme assays
Technique: Cytogenetic Testing
- conventional cytogenetic testing
2. molecular cytogenetics (FISH)
Technique: Sequence Analysis
Type: Molecular
Approach: Direct
methods: Sanger Sequencing or whole-exome testing
Technique: Targeted Mutation Analysis
Type: Molecular Approach: Direct methods: Multiplex PCR Analysis ASO (Allele Specific Oligonucleotide)
Technique: Micro-array Analysis
Type: Molecular Approach: Direct methods: Gene Expression Profiling Microarray CGH (Comparative Genomic Hybridization)
Technique: Indirect molecular testing
Indirect genetic diagnosis determines whether an individual has inherited a chromosome containing the disease gene from his or her parent using DNA polymorphisms linked to the disease gene.
Limitations:
- need for multiple family members
- possibility of recombination between matings
FISH
Fluoresence In-Situ Hybridization
control probe: identifies the chromosome of interest
tag probe: targets a sequence of interests
resolution: 100 kb (minimum probe size)
Whole exome sequencing
to detect mutations in many genes OR
gene panels of interest
ex. panel of alleles known to be associated with cardiomyopathy
Limitations:
- fails to target sequences in introns
- by doing the test for just a few mutations, you may not catch ALL possible mutations that cause the diseases